Agathe Rami

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

Catherine Orrell, Debbie Hagins, Elena Belonosova et al. · The Lancet HIV · 2017 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal et al. · Genome Medicine · 2023 · 77 citations · Full text

Life Sciences, Genetics, Immunology +17

A highly virulent variant of HIV-1 circulating in the Netherlands

Chris Wymant, Daniela Bezemer, François Blanquart et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study

Lionel Piroth, Stanislas Pol, Karine Lacombe et al. · Journal of Hepatology · 2010 · 50 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression

Evguenia Krastinova, Camille Lécuroux, Carole Leroy et al. · The Journal of Infectious Diseases · 2015 · 38 citations

Life Sciences, Immunology, Infectious Diseases +13